http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100803639-B1

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D498-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D273-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D331-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D221-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D498-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D498-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-436
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
filingDate 1998-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2008-02-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2008-02-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-100803639-B1
titleOfInvention Tetrazole-containing rapamycin analogs with shortened half-lives
abstract Compounds of formula (I), or pharmaceutically acceptable salts or prodrugs thereof, are immunomodulators and are useful for the treatment of restenosis and immune and autoimmune diseases. In addition, cancer-, fungal proliferation-, restenosis-, post-transplant tissue rejection- and immune- and autoimmune disease-suppressive compositions, with minimal side effects due to shortened half-life, and cancer, fungal proliferation in mammals, Described are methods for inhibiting restenosis, post-transplant tissue rejection, and immune and autoimmune diseases.n n n n n n n n n n n Tetrazole-containing rapamycin analogs, immunosuppressants, immunomodulators, shortened half-lives, immune and autoimmune diseases, cancer, fungal growth, restenosis, tissue rejection after transplantation
priorityDate 1997-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9514023-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467444312

Total number of triples: 33.